AnaptysBio Selects Gable PR of San Diego for National Communications Program During Key Phase... ( AnaptysBio I...)

AnaptysBio Selects Gable PR of San Diego for National Communications Program During Key Phase in Growth

Date:3/2/2009

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company seeking expanded outreach to the biotech and pharma industries, has selected Gable PR of San Diego to provide national public relations and investor communications programs as a key part of the company's strategic growth plan for 2009 and beyond.

San Diego, Calif. (PRWEB) March 2, 2009 -- AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced it has selected Gable PR to provide public relations and investor communications programs as a key part of the company's strategic growth plan for 2009 and beyond. Gable PR is a growing public relations firm based in San Diego and known for its sophisticated and successful approach to managing complex programs for national biotech companies and organizations.

"Gable PR will play a vital role in helping us communicate with key audiences about the advantages of our platform for antibody discovery," said Tom Smart, AnaptysBio chairman and CEO. "We selected Gable PR because of their past successes helping biotech companies with complex messages reach out to broader industry audiences. We anticipate achieving several important milestones in 2009 in validating our platform and need an agency partner that can take charge of getting out the word in a very targeted way to potential partners and investors."

AnaptysBio has developed a platform for generating therapeutic antibodies that is unique in the field. The platform mimics the body's natural evolution and selection processes for creating potent antibodies to fight disease. As a result, AnaptysBio believes the antibodies generated by its platform will result in therapies that are highly effective and better tolerated by the human body. Competing platforms often require scientists make artificial changes to antibodies, resulting in lower likelihood
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
2. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
3. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
4. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
5. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
6. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
7. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
8. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
9. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
10. Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal
11. Fallon Community Health Plan Selects CaseNET to Enhance Care Services Infrastructure

Post Your Comments:

AnaptysBio Selects Gable PR of San Diego for National Communications Program During Key Phase...( AnaptysBio I...),Health